Revvity (RVTY) Other Non-Current Assets (2010 - 2026)
Revvity's (RVTY) quarterly Other Non-Current Assets came in at $309.1 million in Q3 2026, down 3.72% on a YoY basis from $321.1 million in Q3 2025, and down 4.03% quarter-over-quarter from $322.1 million in Q2 2026.
Analysis
Revvity (RVTY) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Revvity (RVTY) has reported Other Non-Current Assets for 17 consecutive years, with $309.1 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Other Non-Current Assets fell 3.72% year-over-year to $309.1 million; the trailing twelve-month figure through Jul 2026 stood at $309.1 million (down 3.72% YoY), and the FY2025 full-year result was $323.5 million, up 12.16% from the prior year.
- Other Non-Current Assets slipped to $309.1 million in Q3 2026 per RVTY's latest filing, from $322.1 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.7 billion in Q1 2022 and bottomed at $288.4 million in Q4 2024.
- Historically, Other Non-Current Assets has averaged $534.5 million across 5 years, with a median of $322.1 million in 2026.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets jumped 415.36% in 2022, then plunged 81.48% in 2023.
- Over 5 years, Other Non-Current Assets stood at $1.7 billion in 2022, then slumped by 79.31% to $343.0 million in 2023, then retreated by 15.91% to $288.4 million in 2024, then rose by 12.16% to $323.5 million in 2025, then decreased by 4.44% to $309.1 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $309.1 million, $322.1 million, and $323.5 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 1.07 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 576.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 309.11 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 264.34 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 101.70 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 4.05 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 15.31 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 816.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 309.11 Mn |
| Apr 5, 2026 | 322.10 Mn |
| Dec 28, 2025 | 323.48 Mn |
| Sep 28, 2025 | 300.44 Mn |
| Jun 29, 2025 | 321.06 Mn |
| Mar 30, 2025 | 299.55 Mn |
| Dec 29, 2024 | 288.40 Mn |
| Sep 29, 2024 | 332.22 Mn |
| Jun 30, 2024 | 296.79 Mn |
| Mar 31, 2024 | 297.64 Mn |
| Dec 31, 2023 | 342.97 Mn |
| Oct 1, 2023 | 307.03 Mn |
| Jul 2, 2023 | 321.57 Mn |
| Apr 2, 2023 | 382.87 Mn |
| Jan 1, 2023 | 1.69 Bn |
| Oct 2, 2022 | 1.66 Bn |
| Jul 3, 2022 | 324.25 Mn |
| Apr 3, 2022 | 334.79 Mn |
| Jan 2, 2022 | 1.70 Bn |
| Oct 3, 2021 | 321.67 Mn |